Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
J Med Genet ; 44(10): e89, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17911653

ABSTRACT

BACKGROUND: The prevalence of lactase persistence is high in Saudi Arabia. OBJECTIVE: To identify a DNA variant for the lactase persistence/non-persistence trait in adult Arabs in Saudi Arabia. METHODS: We sequenced DNA from 432 anonymous neonatal blood donors from five different regions of Saudi Arabia to cover the 400 bp region surrounding the previously identified lactase persistence/non-persistence variant C/T-13910 residing in intron 13 of the MCM6 gene. RESULTS: Two anonymous blood donors carried the C/T-13910 genotype. One variant, T/G -13915, residing 5 bp upstream of the C/T-13910 variant, was present in 332 of 432 (76.9%) of the neonatal samples, compatible with previous prevalence figures of lactase persistence in urban Saudi populations. Determination of disaccharidase activities in 25 intestinal biopsy samples showed a highly significant correlation between lactase activity and the T/G-13915 genotypes (p<0.001; Fisher exact test) as well as between the L:S ratio and the aforementioned genotypes (p<0.001; Fisher exact test). CONCLUSION: The T/G-13915 variant is the founder mutation of lactase persistence in an urban Saudi population. The results obtained here have implications for genetic testing of adult-type hypolactasia and to analysis of human evolution, the origin of cattle domestication and migrations of the populations in the Arabian peninsula.


Subject(s)
Gene Expression Regulation , Genetic Variation , Lactase/genetics , Lactates/metabolism , Alleles , Biopsy , Evolution, Molecular , Founder Effect , Genotype , Humans , Infant, Newborn , Introns , Lactase/physiology , Models, Genetic , Saudi Arabia , Urban Population
2.
Biochem J ; 350 Pt 2: 505-10, 2000 Sep 01.
Article in English | MEDLINE | ID: mdl-10947965

ABSTRACT

We have determined that the mutation of the cysteine-230 residue to either glycine or serine in TRAIL (tumour necrosis factor-alpha-related apoptosis-inducing ligand) results in the formation of a structurally incompetent dimer and a consequent loss of apoptotic activity. Similarly, chemical modification of the thiol residues present in both reduced and Zn(2+)-depleted trimer converts TRAIL into an inactive dimer. We postulate that cysteine-230 plays a critical role in homotrimerization of this tumoricidal cytokine.


Subject(s)
Cysteine/chemistry , Membrane Glycoproteins/chemistry , Membrane Glycoproteins/physiology , Tumor Necrosis Factor-alpha/chemistry , Tumor Necrosis Factor-alpha/physiology , Apoptosis Regulatory Proteins , Chromatography , Colon/pathology , Colonic Neoplasms/pathology , DNA, Complementary/metabolism , Dimerization , Dose-Response Relationship, Drug , Glutathione Transferase/metabolism , Humans , Membrane Glycoproteins/genetics , Mutagenesis, Site-Directed , Recombinant Proteins/chemistry , Recombinant Proteins/metabolism , TNF-Related Apoptosis-Inducing Ligand , Time Factors , Tumor Cells, Cultured , Tumor Necrosis Factor-alpha/genetics , Zinc/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...